This Article Full Text Full Text (PDF) All Versions of this Article: 2005-0063OCv1 32/6/531    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jeyaseelan, S. Articles by Worthen, G. S. Search for Related Content PubMed PubMed Citation Articles by Jeyaseelan, S. Articles by Worthen, G. S.

Induction of CXCL5 During Inflammation in the Rodent Lung Involves Activation of Alveolar Epithelium

Division of Respiratory Infections, and Division of Pulmonary Diseases, Department of Medicine, National Jewish Medical and Research Center; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado; and Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan

Correspondence and requests for reprints should be addressed to Samithamby Jeyaseelan, D.V.M., Ph.D., Department of Medicine, National Jewish Medical and Research Center, 1400 Jackson Street Neustadt D-403, Denver, CO 80206. E-mail: JeyaseelanS{at}njc.org

The lung is continuously exposed to bacteria and their products, and has developed a complex defense mechanism, including neutrophil recruitment. In mice, keratinocyte cell–derived chemokine and macrophage inflammatory protein-2 are the major chemokines for neutrophil recruitment into the lung. We have previously described a role for C-X-C chemokine (CXCL5) in neutrophil trafficking during lipopolysaccharide (LPS)-induced lung inflammation in mice. The aims of the present study were to identify the cellular origin of CXCL5 and to determine the signaling cascades that regulate its expression in the lung during LPS-induced inflammation and in isolated LPS-stimulated CXCL5-expressing cells. Our immunohistochemical analysis indicates that alveolar epithelial type II (AEII) cells are the primary source of CXCL5 in the rodent lung. These in vivo observations were confirmed with primary AEII cells. In addition, our data indicate that the Toll-like receptor 4 (TLR4) signaling cascade involving TLR4, myeloid differentiation factor 88, and Toll–IL-1R domain–containing adapter protein is required to induce CXCL5 expression in the lung. Furthermore, p38 and c-Jun N-terminal kinases are involved in lung CXCL5 expression. Similarly, TLR4, and p38 and c-Jun N-terminal kinases, are associated with LPS-induced CXCL5 expression in AEII cells. These novel observations demonstrate that activation of AEII cells via TLR4-dependent signaling is important for the production of CXCL5 in the lung exposed to LPS.

Key Words: lipopolysaccharide • CXCL5 • LIX • lung inflammation • mouse model

This article has been cited by other articles:

				K. Smoak, J. Madenspacher, S. Jeyaseelan, B. Williams, D. Dixon, K. R. Poch, J. A. Nick, G. S. Worthen, and M. B. Fessler Effects of Liver X Receptor Agonist Treatment on Pulmonary Inflammation and Host Defense J. Immunol., March 1, 2008; 180(5): 3305 - 3312. [Abstract] [Full Text] [PDF]

				R G Pillai, S C Beutelspacher, D F P Larkin, and A J T George Upregulation of chemokine expression in murine cornea due to mechanical trauma or endotoxin Br. J. Ophthalmol., February 1, 2008; 92(2): 259 - 264. [Abstract] [Full Text] [PDF]

				T. R. Hawn, W. R. Berrington, I. A. Smith, S. Uematsu, S. Akira, A. Aderem, K. D. Smith, and S. J. Skerrett Altered Inflammatory Responses in TLR5-Deficient Mice Infected with Legionella pneumophila J. Immunol., November 15, 2007; 179(10): 6981 - 6987. [Abstract] [Full Text] [PDF]

				S. Jeyaseelan, S. K. Young, M. B. Fessler, Y. Liu, K. C. Malcolm, M. Yamamoto, S. Akira, and G. S. Worthen Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-beta (TRIF)-Mediated Signaling Contributes to Innate Immune Responses in the Lung during Escherichia coli Pneumonia J. Immunol., March 1, 2007; 178(5): 3153 - 3160. [Abstract] [Full Text] [PDF]

				L. J. Quinton, M. R. Jones, B. T. Simms, M. S. Kogan, B. E. Robson, S. J. Skerrett, and J. P. Mizgerd Functions and Regulation of NF-{kappa}B RelA during Pneumococcal Pneumonia J. Immunol., February 1, 2007; 178(3): 1896 - 1903. [Abstract] [Full Text] [PDF]

				H.-W. Chen, S.-F. Su, C.-T. Chien, W.-H. Lin, S.-L. Yu, C.-C. Chou, J. J. W. Chen, and P.-C. Yang Titanium dioxide nanoparticles induce emphysema-like lung injury in mice FASEB J, November 1, 2006; 20(13): 2393 - 2395. [Abstract] [Full Text] [PDF]

				S. Jeyaseelan, S. K. Young, M. Yamamoto, P. G. Arndt, S. Akira, J. K. Kolls, and G. S. Worthen Toll/IL-1R Domain-Containing Adaptor Protein (TIRAP) Is a Critical Mediator of Antibacterial Defense in the Lung against Klebsiella pneumoniae but Not Pseudomonas aeruginosa J. Immunol., July 1, 2006; 177(1): 538 - 547. [Abstract] [Full Text] [PDF]

				R. Manzer, J. Wang, K. Nishina, G. McConville, and R. J. Mason Alveolar Epithelial Cells Secrete Chemokines in Response to IL-1beta and Lipopolysaccharide but Not to Ozone Am. J. Respir. Cell Mol. Biol., February 1, 2006; 34(2): 158 - 166. [Abstract] [Full Text] [PDF]

				S. Jeyaseelan, R. Manzer, S. K. Young, M. Yamamoto, S. Akira, R. J. Mason, and G. S. Worthen Toll-IL-1 Receptor Domain-Containing Adaptor Protein Is Critical for Early Lung Immune Responses against Escherichia coli Lipopolysaccharide and Viable Escherichia coli J. Immunol., December 1, 2005; 175(11): 7484 - 7495. [Abstract] [Full Text] [PDF]